December 04, 2008A Dirty, False-Lighted PlaceJohn McManamy, who blogs over at HealthCentral.com on bipolar disorder and depression, has for the second time gone after the New York Times and its crack reporter Gardiner Harris, who covers public health for the paper in its DC bureau, in defense of Fred Goodwin and "The Infinite Mind" debacle and an article Harris wrote recently that linked Goodwin to over $1 million in payouts from pharma companies while at the same time Goodwin was saying false things on the now-cancelled radio show about anti-depressants, suicide, suicidality and violence. I need to spell out a fair amount of background for newcomers and tell you why this is important: McManamy is essentially doing PR for Goodwin, who apparently feels that his reputation has been injured by the initial Times piece and a later editorial in the paper, according to informed sources. McManamy is basically claiming that the paper put Goodwin in a false light, and that's pretty darn close to claiming libel, a very serious assertion. Goodwin is much admired by McManamy (Goodwin wrote a cover blurb for McManamy's book "Living Well with Depression and Bipolar Disorder"), and by other researchers in psychiatry. He's a former director of NIMH and is currently a professor of psychiatry at George Washington School of Medicine. Goodwin is also the primary author of what's considered by many observers to be the definitive medical textbook on bipolar disorder. He's as big of a big shot as a big shot can be in psychiatry. But Goodwin has come under harsh criticism of late. On Sunday, the Times opined that conflicts of interest between psychiatric researchers and pharma companies had to be cracked down upon by medical professional societies and Congress. The editorial noted Goodwin's presence in the boiling conflict of interest scandal, and curtly noted that Goodwin "earned at least $1.3 million by giving marketing lectures for drug makers who potentially stood to benefit from the recommendations he made on the program. He has rightly been removed from the air." The next day, Tufts University psychiatrist Danny Carlat wrote on his influential blog that the revelations around Goodwin and Harvard University's Joseph Biederman, a controversial child psychiatrist, were "bringing the profession of psychiatry to its knees." McManamy didn't mention Carlat in his recent defense of Goodwin, nor did he mention my own reporting on an episode of "The Infinite Mind" from last March, where I noted that Goodwin and his guests had lied about questions around anti-depressants, suicide, suicidality and violence. Nor did McManamy mention two pieces the next month, one by Slate.com and one by yours truly, which first delved into conflicts of interest Goodwin and the show itself had. I mention all of that because if McManamy is going to throw around false light claim innuendoes and if Goodwin is torqued about such things, then the pair ought to be slamming myself, Slate.com and Carlat as much as the Times. What's more, both Goodwin and McManamy ought to be criticizing Sen. Charles Grassley (R-Iowa), who's been highlighting these dirty conflicts of interest on the Senate floor and who made public the dollar amounts Goodwin was getting from GlaxoSmithKline and other companies while taking to America's public radio airwaves to proclaim that all is well with the psychopharmacological paradigm and that its critics are essentially loons. It'll sure be interesting to read McManamy's piece on how Sen. Grassley unfairly characterized Goodwin's money-taking and radio propagandizing. But McManamy's big beef is with the Harris article of Nov. 22 (it appeared online on Nov. 21) that reported on Grassley's accusations, the demise of the radio show and detailed what money Goodwin was getting from whom when he was saying what on the radio show. McManamy notes, "Defamation is not simply about facts. It's about (sic) innuendos." In McManamy's case tossing around innuendoes about the Times and Harris might work out better for him if he had some of his basic facts straight. McManamy points out on his HealthCentral.com blog, for which he is paid, that the editorial cast aspersions on Goodwin when it stated, according to McManamy, that: "Dr Goodwin 'potentially stood to benefit from the recommendations he made on the program.'" The only trouble is that that's not what the editorial said. It said: "Goodwin 'earned at least $1.3 million by giving marketing lectures for drug makers who potentially stood to benefit from the recommendations he made on the program.'" In other words, the paper said the drug companies benefitted from what Goodwin said on air, an odd slip in McManamy's case against the paper, but a nice stab at PR spin. McManamy steps further into PR spin weirdness when he writes of the initial Harris piece. "Dr Goodwin tells a far different story. In a public statement he just released, Dr Goodwin reports that prior to the story, he talked for nearly an hour on the phone with NY Times reporter Gardiner Harris, and in an email exchange. According to Dr Goodwin, 'most of the important information I provided was left out of the story.' I don't recall Goodwin ever saying he was in favor of a less-loaded term on the show. And suicidality sure strikes me as being less-loaded than, say, suicide or violence. There is ample evidence for a connection between all three and anti-depressant use, although there is evidence that points in other directions as well. The above McManamy passage, which appears to be at the heart of Goodwin's frustrations with the Times, has another problem as well. Goodwin defended modern anti-depressants on the March radio episode as an entire class--all 12 of them, Prozac, Paxil and the rest--and defended them against links to various problems. Here's what Harris wrote: "He said that he had never given marketing lectures for antidepressant medicines like Prozac, so he saw no conflict with a program he hosted in March titled 'Prozac Nation: Revisited.' which he introduced by saying, 'As you will hear today, there is no credible scientific evidence linking antidepressants to violence or to suicide.' I'm not in a position to say whether or not Goodwin ever spoke on behalf of Paxil. Apparently, the Glaxo money he received recently was for his work on behalf of Lamictal, an anti-seizure drug that is FDA-approved as a maintenance mood stabilizer for bipolar disorder as well as epilepsy. Interestingly, on Jan. 31, 2008, the FDA issued a warning about suicidality reported in anti-seizure drugs including Lamictal. An FDA advisory committee later declined to recommend a full black box warning to that effect for the drugs, but it's ironic that the FDA's warning came almost two months before Goodwin's show defending anti-depressants from similar claims and about two months before Goodwin got a $20,000 check from Glaxo for Lamictal-related activities. Lamictal is not approved to treat bipolar depression, but it's used quite commonly off-label for that purpose. It's interesting to me that Goodwin didn't mention that during his anti-depressant defense radio show. McManamy does make one interesting point, but again it fails to work in his and Goodwin's favor: "Dr Goodwin's long-standing - and highly public - track record reveals he is anything but a pusher of antidepressants. In his definitive book, 'Manic-Depressive Illness,' and in his talks to psychiatrists, Dr Goodwin has come through loud and clear on 'the overuse of antidepressants, especially in children.'" Let's review what Harris wrote again: "Dr. Goodwin earned around $20,000 from GlaxoSmithKline, which for years suppressed studies showing that its antidepressant, Paxil, increased suicidal behaviors." I'm not sure how a casual reader would be left with the impression that Goodwin had been involved in suppressing data on Paxil when Harris specifically wrote that the company itself, GlaxoSmithKline, had done so. Maybe a stupid reader would be, but even careful journalists such as Harris cannot protect the world from inferences drawn by stupid readers and McManamy. And, if Goodwin is such a skeptic of anti-depressants, then why didn't he say so on "The Infinite Mind?" And, why didn't Goodwin, in the statement McManamy refers to (and which I've been unable to find a copy of), question the suicidality-Paxil connection that Harris asserted in his November article? I don't have answers for either question, so I'll simply note the inconsistency. With such off-base assertions as McManamy makes in attacking the Times, you've got to wonder who is editing his copy on HealthCentral.com, a site that as a whole attracts over 1.1 million readers a month, according to Quantcast.com and is littered with ads for pharmaceutical products of all kinds. According to McManamy's blog there, he is an "expert patient." McManamy may have all kinds of useful thoughts to offer in his writing about depression and bipolar disorder, but as a media expert and quasi-legal analyst he's strictly inexpert. Posted by Philip Dawdy at December 4, 2008 12:01 AM
del.icio.us
Digg it
reddit
Comments
Wow. Well said "Papa" Dawdy. Therein lies the difference- Goodwin is the old man, McManamy is the old waiter- and you, you are the young waiter. The old waiter realizes he will have the same fate as the old man.
Mr. Dawdy, you have written a masterpiece, worthy of Hemingway, who's title this piece evokes, or Carver who your site is named from. And Mr. McManamy- he is no Hemingway, or Carver, though he longs to be. I feel sorry for him. Posted by: anon at December 4, 2008 01:16 AMOkay, so I finally listened to the "Prozac Nation: Revisited" broadcast. I listened to Dr. Goodwin's interview with Dr. Leuchter in which they discuss the relationship between suicidality and antidepressants. Man, was this conversation misconstrued! Their main points were as follows: 1. The media sensationalizes the use of antidepressants in disturbed individuals who commit violent crimes while minimizing other factors that are probably more important, such as traumatic childhoods, and disturbed thoughts and behaviour preceding medication use. 2. The term "suicidality" used in the FDA studies is inadequate, because it conflates suicidal ideation and gestures with completed suicides, of which there were none in the FDA studies. Dr. Goodwin stated that a better term should be invented to describe the arousal, agitation and disturbed behaviour of those who have paradoxical reactions on antidepressants, especially given the fact that there were no completed suicides in those studies. Also, he mentioned a large prospective study where there was a negative correlation between suicidal ideation and completed suicides, because those who seriously want to kill themselves will not tell anyone to prevent their plan from being thwarted. He stated that those who express suicidal ideation should be taken seriously as an expression of distress, but he denied that they were at increased risk of dying. Dr. Leuchter stated that studies have shown that just having suicidal ideation is not correlated with completed suicides, but having suicidal ideation, plus severe anxiety and insomnia, in the context of a depression, then that is a risk factor for completed suicides, and those people “need to be monitored most closely”. 3. They explicitly mentioned at around 8:10 that in some vulnerable individuals they could have a “paradoxical reaction” to the antidepressants, but that these situations are rare and that they have more to do with the unusual wiring of their brain rather than the medication. Dr. Leuchter agreed that there are “unpredictable reactions” that can occur especially in adolescents and young adults under the age of 25, mainly due to an undeveloped frontal lobe. He then said that these reactions “are extremely rare, but they do occur”. This is actually what the literature says. 4. Dr. Goodwin and Dr. Leuchter explicitly stated that for mild to moderate forms of depression, medications and psychotherapy are equivalent, but that for severe forms of depression, medications are essential, and that the best outcomes actually have medications and psychotherapy to reduce relapse rates. 5. They did describe epidemiological data that showed that as antidepressant prescriptions have gone down, completed suicides have gone up. This is probably the most debatable part of their presentation, as the evidence here seems pretty weak and inconclusive. I have not listened to the rest of the broadcast, but the first third of it appears quite appropriate to me. They did not deny the signficant risks of antidepressants, but stated that they are rare and should be monitored for, which I think is appropriate. I think that much of the controversy, as pointed out by Dr. Goodwin, is due to the term "suicidality" that includes both suicidal thoughts and gestures, and completed suicides, and that when they say there is no evidence of a link between antidepressants and suicide, they are describing completed suicides, but they certainly do not deny a moderate increase in suicidal thinking in those under the age of 25, which is what the latest meta-analyses have shown. Posted by: dguller at December 4, 2008 05:30 AMPhilip: A question: Isn't Lamictal ON-LABEL for bipolar, type I? Albeit for chronic ("maintenance") bipolar disorder rather than acute episodes. Because Glaxo sure advertises it that way; and I remember a lot of publicity for Lamictal being FDA-approved for bipolar I ... Posted by: Larry at December 4, 2008 08:35 AMMy dog is named after Hemingway. As for McManamy, I got into it on his blog once about the bipolar child - imagine that! It was after Katie Couric did a story on Rebecca Riley. There seem to be three popular perspectives on bipolar disorder, the folks like McManamy and Jamison who cling to the idea that bipolar disorder is a real medical disease and that people who have it are superior, more human than others, touched with fire, you get it, then there's folks like Torrey, and probably Goodwin given his undisputed eugenics background that argue that bipolar disorder is a genetic defect and thus people who have it are so dangerous to society, so much less than human, that their rights don't matter, they must be at the very least medicated and often confined against their will. Then there's the middle ground where reasonable people understand that life can be horribly painful and confusing and that people who feel and experience pain and confusion should be treated with dignity, sympathy and compassion as we are all human. Meanwhile, I just love this quote:"suicidality," which they felt embraced a range of behaviors far too wide to show a credible link. Dr Goodwin was in favor of a less-loaded term." I'd love to hear about the "range of behaviors." From the context I'd assume none of them involved being cured, or as they say clinically significant decrease in symptoms and all were on the self harm side of the spectrum. Just imagine a doctor reasoning that it's okay to give someone a pill that will make suicide more likely and rationalizing that it's okay because the suicidality information will make the patient scared to take the pill. Then the patient commits suicide and the doctor blames it on the disease, convenient excuse. It's like treating diabetes with sugar pills, Goodwin deserves prison and McManamy is sad as he really seems to believe his own party line. Posted by: Sally at December 4, 2008 09:10 AMSally: First, I think that what Dr. Goodwin meant was that there is a diffence between: (1) Suicidal thoughts. All three are concerning, but it is misrepresentation to say that (1) and (2) are equivalent to (3), because they are not. People express suicidal thinking for a variety of reasons, not always to communicate a genuine intention to die. Also, people engage in suicidal gestures, e.g. cutting, for a variety of reasons, not always with an intention to die. Even completed suicides sometimes occur accidentally where someone is attempting to arrange a cry for help, but ends up going too far. The point is that it is a muddy area that requires some clear conceptual distinctions, because otherwise conclusions will be muddled and unhelpful. Second, I am not too sure what you were trying to say at the end of your post. No doctor would give someone a medication that WILL make suicide more likely, but I think that many physicians would say that they would prescribe a medication that COULD increase suicidal thinking in a minority of cases, if there was a demonstrable benefit to taking the medication in other areas. Steroids could result in suicidal thinking, but we would not stop using them in asthma patients, autoimmune patients, and so on, becuase the benefits outweigh the risks. Posted by: dguller at December 4, 2008 09:48 AMDguller, I know that steroids can result in suicidal thinking because a doctor told me. I assume that someone who is unhappy and taking steroids is monitored for mood, and I bet more closely than someone who gets psych drugs from a psychiatrist for various reasons. In my understanding a suicidal gesture is an attempt to commit suicide, maybe insincere, but still an action towards suicide. I can't help but think that giving a drug that may increase suicidal thinking, i.e. may make you wish you were dead, to someone who is already so unhappy that don't want to live increases the risk of suicide, and a drug that makes you attempt suicide or set up a situation where it looks that suicide is likely to get attention increases the likelihood of suicide, unless you are arguing that completed suicide is a spontaneous event that the deceased never thinks of before doing. In the unlikely event that is your argument, I'd really have to wonder about the source of your data. What if the black box warning said "may may you wish to end your own life, may make you pretend to attempt suicide to get attention from others." Exactly what sort of marketing tool would that be? Posted by: Sally at December 4, 2008 01:26 PMSally: You make fair points about suicide, but I think you still miss much of the range of suicidal ideation, gestures and completed termination. However, that is not especially relevant to your point. You argue that giving individuals who are already severely depressed and suicidal medications that have a risk of worsening their suicidal tendencies is foolish, to say the least. You would be correct, if that was all the medications did. However, you leave out the other features of those medications, including increase in energy and motivation, improvement in mood, sleep, appetite and concentration, all of which are important markers for the relief of depression. When you factor those other components into the equation, the situation does not appear quite so ridiculous, I think. Furthermore, I doubt if the increase in suicidal tendencies occurs in a vacuum in individuals on antidepressants. From what I understand, it is the end result of other mental status changes, including induction of a mixed state, akathasia, electrolyte changes due to SIADH, and so on, in a minority of vulnerable patients. All of those conditions create extreme psychological distress, which is what drives those subjects to have suicidal ideation, even when none existed before. In those depressed and suicidal individuals on antidepressants who find relief in their mood and neurovegetative symptoms, and do not experience the adverse mental status changes mentioned above, then it appears quite clear that their suicidal tendencies would likely reduce. Fortunately, those paradoxical effects of antidepressants are not very common, even in those under the age of 25, but they should still be monitored and patients should be warned for their own protection. Posted by: dguller at December 4, 2008 10:23 PMDguller, Interesting response. Sorry for taking it out of order. I give, what are electrolyte changes due to SIADH? What is SIADH? I'm thinking that SSRI's drive people who already have suicidal ideation to kill themselves and that surely for a diagnosis of depression you have to have suicidal ideation, though maybe the criteria for depression really are as broad this days as the DTC ads would have us believe, which means any woman who doesn't wear lipstick or in the face of all that is good and decent goes to the grocery store in a sweat shirt, is clinically depressed. Regarding suicide and ssri's, you write: "However, you leave out the other features of those medications, including increase in energy and motivation, improvement in mood, sleep, appetite and concentration, all of which are important markers for the relief of depression." My theory is that when someone is suicidal, it's for a reason, relationship, family, financial, at least with the suicides I've known. Look at the news stories about people who commit suicide because of home foreclosure, unemployment, etc. For people like this, curing what you call depression may cause suicide. In other words, if you've made a plan to commit suicide and you're really down you're no more likely to follow through with it than you are with the plan to wash your dishes but the ssri's make you feel more energetic and hungrier, i.e. better able to accomplish your goal be it curing cancer or killing yourself. Being more energetic is not the same as being less depressed but is similar to akathasia, nor is increased appetite. In fact it's amazing that, with the exception of SIADH which I'm unfamiliar with, the causes of suicide you suspect listed below are virtually a list of the expected side effects of ssri's. "From what I understand, it is the end result of other mental status changes, including induction of a mixed state, akathasia, electrolyte changes due to SIADH, and so on, in a minority of vulnerable patients. All of those conditions create extreme psychological distress, which is what drives those subjects to have suicidal ideation, even when none existed before." Posted by: Sally at December 5, 2008 06:13 AMSally: First, SIADH is the syndrome of inappropriate anti-diuretic hormone (ADH), which causes water retention, which dilutes electrolyte levels, especially sodium. Low sodium concentration can cause mental status and personality changes. SSRI's are known to cause SIADH in some individuals. Second, one does not have to be suicidal to be diagnosed with depression, at least not according to the DSM-IV. Third, you are correct that there are a variety of stressors that lead to depression and suicidal ideation. However, it is not the stressors themselves, but rather their impact on the individual's cognitive, emotional and behavioural function. For example, some people respond to losses with indifference, and other respond with severe depression. So, it stands to reason that part of helping people out of depression is improving the cognitive, emotional and behavioural sign and symptoms of depression, which medications are helpful for, in addition to teaching coping skills to deal with the stressors. Fourth, you are correct that one of the possible underlying mechanisms of increased suicides with SSRI's is that some people get their energy back before their other depressive symptoms return. This does not appear to happen often, and with proper monitoring can likely be avoided. Fifth, you shouldn't be amazed that the list of underlying mechanisms that I listed could be found on the side effect list of SSRI's. That's exactly what I was saying in the first place. Posted by: dguller at December 5, 2008 11:09 AMDguller, said, "Fourth, you are correct that one of the possible underlying mechanisms of increased suicides with SSRI's is that some people get their energy back before their other depressive symptoms return." Is it that they get their energy back or is it that they have increased agitated energy? I have heard mental health professionals claim what you've said, but I haven't seen data to back it up. I had a prof say that "people are feeling better so now they have the energy to act on their suicidal thoughts." Say what? I'm feeling so much better, I think I'll go commit suicide now? It doesn't make sense to me that if someone is feeling so much more energetic they would suddenly commit suicide - unless the energy they're feeling is agitated energy. Posted by: Lisa at December 6, 2008 09:52 AMLisa: Both can happen. Normal energy levels can be dangerous if someone has a depressed mood and suicidal thoughts. Extreme agitation can be dangerous whether one is depressed or not, because it is very dysphoric and uncomfortable. Posted by: dguller at December 6, 2008 06:11 PMPost a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

